Nnit AS (NNIT)
Copenhagen Exchange · Denmark · prices in DKK · close of 22 Oct 2026
Key indicators
| Last close | DKK 45.50 |
|---|---|
| 52-week range | 33.05 – 57.80 |
| Return, 1 month / 3 months | +23.0% / +20.1% |
| Return, 1 year / 3 years | −18.3% / −43.5% |
| Trend | Uptrend |
| RSI (14) | 77 |
| Volatility (1 year) | 35.5% |
| Worst drawdown (1 year) | -41.6% |
| Average daily value traded | 0.61M DKK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NNIT is a Danish information technology services company based in Copenhagen. It advises organisations on their IT systems and builds and operates software for them, with a particular focus on customers in the life sciences industry as well as public sector and enterprise clients. Its work covers consulting, application development, infrastructure management and outsourcing, helping organisations run and modernise their technology operations.
Nnit AS trades under the code NNIT on the Copenhagen Exchange in Denmark, with its price quoted in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nnit AS (NNIT) trades on the Copenhagen Exchange in Denmark. It last closed at DKK 45.50 on 22 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 105 of 164 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 18.3% and over the last three months it rose 20.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Copenhagen Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 10.8% | ||
| From 52-week high | -20.7% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 20.1% | ||
| 6-month return | 2.8% | ||
| 12-month return, skipping the last month | -33.6% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.6% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.61M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +23.0% |
|---|---|
| 1 month | +23.0% |
| 3 months | +20.1% |
| 6 months | +2.8% |
| 1 year | −18.3% |
| 3 years | −43.5% |
| 5 years | −63.9% |
Signals
| 50-day / 200-day average | 38.26 / 41.08 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.77 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Mar 2021 | DKK 1.0000 |
| 17 Aug 2020 | DKK 2.0000 |
| 6 Mar 2020 | DKK 2.0000 |
| 19 Aug 2019 | DKK 2.0000 |
| 8 Mar 2019 | DKK 2.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Copenhagen Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.